These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15331714)

  • 1. Capsid region involved in hepatitis A virus binding to glycophorin A of the erythrocyte membrane.
    Sánchez G; Aragonès L; Costafreda MI; Ribes E; Bosch A; Pintó RM
    J Virol; 2004 Sep; 78(18):9807-13. PubMed ID: 15331714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of bovine parvovirus to erythrocyte membrane sialylglycoproteins.
    Thacker TC; Johnson FB
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2163-9. PubMed ID: 9747725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of anti-idiotypic antibodies mimicking antibody- and receptor-binding sites on hepatitis A virus.
    Kiyohara T; Totsuka A; Yoneyama T; Ishii K; Ito T; Wakita T
    Arch Virol; 2009; 154(8):1263-9. PubMed ID: 19578927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A virus mutant spectra under the selective pressure of monoclonal antibodies: codon usage constraints limit capsid variability.
    Aragonès L; Bosch A; Pintó RM
    J Virol; 2008 Feb; 82(4):1688-700. PubMed ID: 18057242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single mutation in the glycophorin A binding site of hepatitis A virus enhances virus clearance from the blood and results in a lower fitness variant.
    Costafreda MI; Ribes E; Franch A; Bosch A; Pintó RM
    J Virol; 2012 Aug; 86(15):7887-95. PubMed ID: 22593170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the cell and erythrocyte binding activities of the dimple and canyon regions of the canine parvovirus capsid.
    Tresnan DB; Southard L; Weichert W; Sgro JY; Parrish CR
    Virology; 1995 Aug; 211(1):123-32. PubMed ID: 7645206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel CD4+ T-helper lymphocyte epitope in the VP3 protein of hepatitis A virus.
    Sánchez G; Pintó RM; Bosch A
    J Med Virol; 2004 Apr; 72(4):525-32. PubMed ID: 14981753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homogeneous hepatitis A virus particles. Proteolytic release of the assembly signal 2A from procapsids by factor Xa.
    Rachow A; Gauss-Müller V; Probst C
    J Biol Chem; 2003 Aug; 278(32):29744-51. PubMed ID: 12782637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Antibodies against Hepatitis A Virus (HAV) by a Surface Plasmon Resonance (SPR) Biosensor: A New Diagnosis Tool Based on the Major HAV Capsid Protein VP1 (SPR-HAVP1).
    Santos GMCD; Alves CR; Pinto MA; Amado Leon LA; Souza-Silva F
    Sensors (Basel); 2021 May; 21(9):. PubMed ID: 34063564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Features of antigen-antibody interaction during use of linear synthetic peptides and multipeptide antigen modeling antigenic determinants of hepatitis A virus].
    Kruglov IV; Simonova TV; Perez JA; Haro I
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):31-4. PubMed ID: 19459474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis in Albanian children: molecular analysis of hepatitis A virus isolates.
    Gabrieli R; Sanchez G; Macaluso A; Cenko F; Bino S; Palombi L; Buonomo E; Pinto RM; Bosch A; Divizia M
    J Med Virol; 2004 Apr; 72(4):533-7. PubMed ID: 14981754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of hepatitis A virus in a mouse liver cell line.
    Feigelstock DA; Thompson P; Kaplan GG
    J Virol; 2005 Mar; 79(5):2950-5. PubMed ID: 15709014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.
    Cao J; Meng S; Li C; Ji Y; Meng Q; Zhang Q; Liu F; Li J; Bi S; Li D; Liang M
    J Med Virol; 2008 Jul; 80(7):1171-80. PubMed ID: 18461629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attachment of bovine parvovirus to O-linked alpha 2,3 neuraminic acid on glycophorin A.
    Blackburn SD; Cline SE; Hemming JP; Johnson FB
    Arch Virol; 2005 Jul; 150(7):1477-84. PubMed ID: 15750863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of HAV strains recovered from patients with acute hepatitis from Southern Italy.
    Chironna M; Grottola A; Lanave C; Villa E; Barbuti S; Quarto M
    J Med Virol; 2003 Jul; 70(3):343-9. PubMed ID: 12766995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis].
    Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC
    Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological characterization of the erythrocyte membrane related to myxovirus receptors.
    Bächi I
    Acta Histochem Suppl; 1980; 22():291-7. PubMed ID: 6789386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four chimpanzee monoclonal antibodies isolated by phage display neutralize hepatitis a virus.
    Schofield DJ; Satterfield W; Emerson SU; Purcell RH
    Virology; 2002 Jan; 292(1):127-36. PubMed ID: 11878915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early events of polyoma infection: adsorption, penetration and nuclear transport.
    Consigli RA; Haynes JI; Chang D; Grenz L; Richter D
    Trans Kans Acad Sci; 1992 Apr; 95(1-2):62-9. PubMed ID: 11538202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for neutralization of hepatitis A virus informs a rational design of highly potent inhibitors.
    Cao L; Liu P; Yang P; Gao Q; Li H; Sun Y; Zhu L; Lin J; Su D; Rao Z; Wang X
    PLoS Biol; 2019 Apr; 17(4):e3000229. PubMed ID: 31039149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.